An update on inflammatory arthropathies including pharmacologic management and preoperative considerations.
This article provides an update and overview to the clinical presentations of inflammatory arthropathies. Subtleties to clinical presentations are discussed. Clues are presented which helps the reader arrive at more precise diagnostic labeling. Additionally, pharmacotherapy will be discussed, including precautions in considering the best therapy for the patient with suspected inflammatory, autoimmune, degenerative or neuropathic pain conditions. Finally, preoperative evaluations, management and risks of this patient population are reviewed. Emphasis will be on whether "cardiac clearance" should be requested based on an easy to use algorithm of cardiac risk factors. Finally recommendations based on recent literature of whether immunosuppressants should be withheld preoperatively.
Regule
David
D
Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, 4209 State Route 44, Rootstown, OH 44272, USA. dregule@yahoo.com
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001168:Arthritis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D003937:Diagnosis, Differential; D005534:Foot Diseases / Q000175:diagnosis / Q000628:therapy*; D033023:Foot Joints / Q000503:physiopathology; D006073:Gout / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D018579:Patient Selection; D010808:Physical Examination; D011300:Preoperative Care; D013585:Synovitis / Q000175:diagnosis / Q000628:therapy; D014527:Uric Acid / Q000032:analysis
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D014527:Uric Acid